Annual CFF:
$20.52M+$325.77M(+106.72%)Summary
- As of today, JAZZ annual cash from financing is $20.52 million, with the most recent change of +$325.77 million (+106.72%) on December 31, 2024.
 - During the last 3 years, JAZZ annual cash from financing has fallen by -$3.95 billion (-99.48%).
 - JAZZ annual cash from financing is now -99.48% below its all-time high of $3.97 billion, reached on December 31, 2021.
 
Performance
JAZZ Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$124.53M+$688.94M(+84.69%)Summary
- As of today, JAZZ quarterly cash from financing is -$124.53 million, with the most recent change of +$688.94 million (+84.69%) on June 30, 2025.
 - Over the past year, JAZZ quarterly cash from financing has increased by +$36.56 million (+22.70%).
 - JAZZ quarterly cash from financing is now -102.67% below its all-time high of $4.66 billion, reached on June 30, 2021.
 
Performance
JAZZ Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$699.84M+$36.56M(+4.96%)Summary
- As of today, JAZZ TTM cash from financing is -$699.84 million, with the most recent change of +$36.56 million (+4.96%) on June 30, 2025.
 - Over the past year, JAZZ TTM cash from financing has dropped by -$303.40 million (-76.53%).
 - JAZZ TTM cash from financing is now -114.84% below its all-time high of $4.72 billion, reached on June 30, 2021.
 
Performance
JAZZ TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
JAZZ Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM | 
|---|---|---|---|
| 1Y1 Year | +106.7% | +22.7% | -76.5% | 
| 3Y3 Years | -99.5% | -1255.5% | +28.0% | 
| 5Y5 Years | +107.0% | -119.4% | -282.1% | 
JAZZ Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -99.5% | +103.9% | -150.5% | +84.7% | -3511.2% | +12.1% | 
| 5Y | 5-Year | -99.5% | +103.9% | -102.7% | +84.7% | -114.8% | +28.0% | 
| All-Time | All-Time | -99.5% | +103.9% | -102.7% | +84.7% | -114.8% | +28.0% | 
JAZZ Cash From Financing History
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Jun 2025 | -  | -$124.53M(+84.7%)  | -$699.84M(+5.0%)  | 
| Mar 2025 | -  | -$813.47M(-9730.4%)  | -$736.40M(-3689.4%)  | 
| Dec 2024 | $20.52M(+106.7%)  | -$8.28M(-103.4%)  | $20.52M(+128.7%)  | 
| Sep 2024 | -  | $246.43M(+253.0%)  | -$71.52M(+82.0%)  | 
| Jun 2024 | -  | -$161.09M(-184.8%)  | -$396.44M(-19.4%)  | 
| Mar 2024 | -  | -$56.55M(+43.6%)  | -$332.02M(-8.8%)  | 
| Dec 2023 | -$305.25M(+42.3%)  | -$100.31M(-27.8%)  | -$305.25M(-64.7%)  | 
| Sep 2023 | -  | -$78.49M(+18.8%)  | -$185.35M(+53.2%)  | 
| Jun 2023 | -  | -$96.67M(-224.5%)  | -$395.91M(-37.2%)  | 
| Mar 2023 | -  | -$29.79M(-252.0%)  | -$288.47M(+45.5%)  | 
| Dec 2022 | -$529.49M(-113.3%)  | $19.60M(+106.8%)  | -$529.49M(+33.5%)  | 
| Sep 2022 | -  | -$289.05M(-2782.1%)  | -$795.70M(+18.1%)  | 
| Jun 2022 | -  | $10.78M(+104.0%)  | -$971.82M(-126.4%)  | 
| Mar 2022 | -  | -$270.81M(-9.8%)  | $3.68B(-7.3%)  | 
| Dec 2021 | $3.97B(+651.9%)  | -$246.61M(+47.0%)  | $3.97B(-7.1%)  | 
| Sep 2021 | -  | -$465.18M(-110.0%)  | $4.27B(-9.4%)  | 
| Jun 2021 | -  | $4.66B(>+9900.0%)  | $4.72B(+579.4%)  | 
| Mar 2021 | -  | $18.28M(-67.3%)  | $694.03M(+31.4%)  | 
| Dec 2020 | $528.07M(+279.8%)  | $55.88M(+346.6%)  | $528.07M(+37.4%)  | 
| Sep 2020 | -  | -$22.66M(-103.5%)  | $384.42M(-0.8%)  | 
| Jun 2020 | -  | $642.53M(+535.1%)  | $387.61M(+224.6%)  | 
| Mar 2020 | -  | -$147.68M(-68.2%)  | -$311.08M(-5.9%)  | 
| Dec 2019 | -$293.75M(+37.9%)  | -$87.78M(-351.0%)  | -$293.75M(+55.0%)  | 
| Sep 2019 | -  | -$19.46M(+65.3%)  | -$652.42M(-0.8%)  | 
| Jun 2019 | -  | -$56.15M(+56.9%)  | -$646.93M(-16.5%)  | 
| Mar 2019 | -  | -$130.35M(+70.8%)  | -$555.50M(-17.5%)  | 
| Dec 2018 | -$472.72M(-15.5%)  | -$446.46M(-3095.4%)  | -$472.72M(-613.5%)  | 
| Sep 2018 | -  | -$13.97M(-139.6%)  | -$66.25M(-162.4%)  | 
| Jun 2018 | -  | $35.28M(+174.2%)  | -$25.25M(+90.8%)  | 
| Mar 2018 | -  | -$47.58M(-19.0%)  | -$275.01M(+32.8%)  | 
| Dec 2017 | -$409.11M(-175.6%)  | -$39.98M(-247.9%)  | -$409.11M(+24.4%)  | 
| Sep 2017 | -  | $27.03M(+112.6%)  | -$541.17M(-265.5%)  | 
| Jun 2017 | -  | -$214.48M(-18.1%)  | $327.02M(-36.1%)  | 
| Mar 2017 | -  | -$181.67M(-5.6%)  | $511.77M(-5.4%)  | 
| Dec 2016 | $540.99M(+352.5%)  | -$172.04M(-119.2%)  | $540.99M(-8.2%)  | 
| Sep 2016 | -  | $895.23M(+3110.7%)  | $589.24M(+247.2%)  | 
| Jun 2016 | -  | -$29.73M(+80.5%)  | -$400.40M(-10.2%)  | 
| Mar 2016 | -  | -$152.46M(-23.2%)  | -$363.45M(-69.6%)  | 
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Dec 2015 | -$214.25M(-130.1%)  | -$123.79M(-31.1%)  | -$214.25M(-116.3%)  | 
| Sep 2015 | -  | -$94.42M(-1407.3%)  | -$99.06M(-138.3%)  | 
| Jun 2015 | -  | $7.22M(+321.5%)  | $258.63M(+22.0%)  | 
| Mar 2015 | -  | -$3.26M(+62.1%)  | $211.95M(-70.3%)  | 
| Dec 2014 | $712.88M(+3066.7%)  | -$8.60M(-103.3%)  | $712.88M(+2.9%)  | 
| Sep 2014 | -  | $263.27M(+767.3%)  | $692.58M(+80.6%)  | 
| Jun 2014 | -  | -$39.45M(-107.9%)  | $383.59M(-18.5%)  | 
| Mar 2014 | -  | $497.66M(+1822.3%)  | $470.50M(+2058.1%)  | 
| Dec 2013 | -$24.03M(-105.4%)  | -$28.90M(+36.8%)  | -$24.03M(-384.1%)  | 
| Sep 2013 | -  | -$45.72M(-196.3%)  | $8.46M(-82.6%)  | 
| Jun 2013 | -  | $47.46M(+1414.7%)  | $48.69M(-89.6%)  | 
| Mar 2013 | -  | $3.13M(-12.7%)  | $469.89M(+4.8%)  | 
| Dec 2012 | $448.53M(+1455.8%)  | $3.59M(+165.4%)  | $448.53M(+0.2%)  | 
| Sep 2012 | -  | -$5.49M(-101.2%)  | $447.74M(+6.7%)  | 
| Jun 2012 | -  | $468.65M(+2671.5%)  | $419.62M(+968.5%)  | 
| Mar 2012 | -  | -$18.23M(-750.7%)  | -$48.32M(-46.1%)  | 
| Dec 2011 | -$33.08M(-20.2%)  | $2.80M(+108.3%)  | -$33.08M(+25.0%)  | 
| Sep 2011 | -  | -$33.61M(-4774.8%)  | -$44.10M(-196.1%)  | 
| Jun 2011 | -  | $719.00K(+124.0%)  | -$14.89M(+43.7%)  | 
| Mar 2011 | -  | -$2.99M(+63.6%)  | -$26.47M(+3.8%)  | 
| Dec 2010 | -$27.53M(-367.8%)  | -$8.22M(-86.8%)  | -$27.53M(-82.5%)  | 
| Sep 2010 | -  | -$4.40M(+59.5%)  | -$15.08M(-1621.7%)  | 
| Jun 2010 | -  | -$10.86M(-168.2%)  | -$876.00K(-108.7%)  | 
| Mar 2010 | -  | -$4.05M(-195.9%)  | $10.11M(-1.7%)  | 
| Dec 2009 | $10.28M(-84.0%)  | $4.22M(-56.9%)  | $10.28M(+50.4%)  | 
| Sep 2009 | -  | $9.80M(+7620.5%)  | $6.83M(-62.5%)  | 
| Jun 2009 | -  | $127.00K(+103.3%)  | $18.20M(-14.7%)  | 
| Mar 2009 | -  | -$3.88M(-599.4%)  | $21.33M(-66.7%)  | 
| Dec 2008 | $64.13M(-35.7%)  | $776.00K(-96.3%)  | $64.13M(-1.3%)  | 
| Sep 2008 | -  | $21.17M(+549.7%)  | $64.98M(+52.5%)  | 
| Jun 2008 | -  | $3.26M(-91.6%)  | $42.62M(-69.0%)  | 
| Mar 2008 | -  | $38.92M(+2289.4%)  | $137.69M(+38.0%)  | 
| Dec 2007 | $99.75M(-14.9%)  | $1.63M(+237.2%)  | $99.75M(+1.7%)  | 
| Sep 2007 | -  | -$1.19M(-101.2%)  | $98.12M(-1.2%)  | 
| Jun 2007 | -  | $98.32M(+9841.4%)  | $99.31M(>+9900.0%)  | 
| Mar 2007 | -  | $989.00K  | $989.00K  | 
| Dec 2006 | $117.19M(-39.2%)  | -  | -  | 
| Dec 2005 | $192.85M(+237.4%)  | -  | -  | 
| Dec 2004 | $57.16M  | -  | -  | 
FAQ
- What is Jazz Pharmaceuticals plc annual cash from financing?
 - What is the all-time high annual cash from financing for Jazz Pharmaceuticals plc?
 - What is Jazz Pharmaceuticals plc annual cash from financing year-on-year change?
 - What is Jazz Pharmaceuticals plc quarterly cash from financing?
 - What is the all-time high quarterly cash from financing for Jazz Pharmaceuticals plc?
 - What is Jazz Pharmaceuticals plc quarterly cash from financing year-on-year change?
 - What is Jazz Pharmaceuticals plc TTM cash from financing?
 - What is the all-time high TTM cash from financing for Jazz Pharmaceuticals plc?
 - What is Jazz Pharmaceuticals plc TTM cash from financing year-on-year change?
 
What is Jazz Pharmaceuticals plc annual cash from financing?
The current annual cash from financing of JAZZ is $20.52M
What is the all-time high annual cash from financing for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual cash from financing is $3.97B
What is Jazz Pharmaceuticals plc annual cash from financing year-on-year change?
Over the past year, JAZZ annual cash from financing has changed by +$325.77M (+106.72%)
What is Jazz Pharmaceuticals plc quarterly cash from financing?
The current quarterly cash from financing of JAZZ is -$124.53M
What is the all-time high quarterly cash from financing for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly cash from financing is $4.66B
What is Jazz Pharmaceuticals plc quarterly cash from financing year-on-year change?
Over the past year, JAZZ quarterly cash from financing has changed by +$36.56M (+22.70%)
What is Jazz Pharmaceuticals plc TTM cash from financing?
The current TTM cash from financing of JAZZ is -$699.84M
What is the all-time high TTM cash from financing for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high TTM cash from financing is $4.72B
What is Jazz Pharmaceuticals plc TTM cash from financing year-on-year change?
Over the past year, JAZZ TTM cash from financing has changed by -$303.40M (-76.53%)